Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
INTELLIPHARMACEU RG (NQ: IPCI)
2.210 USD  -0.010 (-0.45%)
Official Closing Price  /  Updated: 8:10 PM EDT, Jun 28, 2017  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 113,652
Open 2.200
Bid (Size) 1.920 (1000)
Ask (Size) 2.250 (1000)
Prev. Close 2.220
Today's Range 2.160 - 2.246
52wk Range 1.510 - 3.350
Shares Outstanding 30,538,162
Dividend Yield N/A
Performance
YTD
-23.26%
-23.26%
1 Month
+15.71%
+15.71%
3 Month
-15.00%
-15.00%
6 Month
-21.63%
-21.63%
1 Year
+44.44%
+44.44%
Top News
More News
Intellipharmaceutics Announces Launch of Generic Seroquel XR® by Mallinckrodt
Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel... Read More
from GlobeNewswire News Releases
Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement to Replace Expiring Shelf Registration Statement
Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel... Read More
from GlobeNewswire News Releases
More News
Read More
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical
from GlobeNewswire News Releases
Intellipharmaceutics Announces FDA Final Approval of Generic Seroquel XR®
from GlobeNewswire News Releases
NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on June 6, 2017
category MYSZ , SGLB , NK , and 8 more.
from NetworkNewsWire
Intellipharmaceutics Reports Director Election Results
from GlobeNewswire News Releases
Intellipharmaceutics Announces First Quarter 2017 Results
from GlobeNewswire News Releases
Intellipharmaceutics Announces Patent Litigation by Purdue against its Rexista™ Abuse-Deterrent Extended-Release Oxycodone
from GlobeNewswire News Releases
NetworkNewsBreaks – Intellipharmaceutics International, Inc. (NASDAQ: IPCI) Leveraging Hypermatrix™ Technology to Address Key Pharmaceutical Markets
category IPCI , NetworkNewsWire Release
from NetworkNewsWire
Intellipharmaceutics Announces TSX Trading Symbol Change to “IPCI”
from GlobeNewswire News Releases
NetworkNewsBreaks – Aegis Capital Reiterates ‘Hold’ Rating, $2 PT on Intellipharmaceutics International, Inc. (NASDAQ: IPCI)
category NetworkNewsWire Release , IPCI
from NetworkNewsWire
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial